BYD’s luxury car brand Yangwang launches Altior electric car in Abu Dhabi
Chinese BYD’s luxury car brand Yangwang has unveiled the all-electric Altior model at a world premiere in Abu Dhabi. Altior is 5.6 metres long and has a four-seat coupé. The model is based on BYD’s e4 platform with four individually controlled electric motors that adjust the torque to each wheel more than 100 times per […]
Svolders’ NAV fell SEK 1 to SEK 62 last week
Investment company Svolders’ NAV decreased by SEK 1 during the past week to SEK 62 per share. Since the start of the year, NAV including reinvested dividends has increased 8 percent, compared with 5 percent for the small-cap index CSRX. In 2025, NAV increased 11 percent compared with 2 percent for the index. The latest […]
Akobo Minerals produced 12 kilos of gold in October – resumes exploration drilling
Gold producer Akobo Minerals produced approximately 12 kilos of doré gold at the Segele mine in Ethiopia during October, with an average processed gold grade of 11 grams per tonne. Total production since operations began thus amounts to approximately 181 kilos, with an average grade of 22 grams per tonne. The lower gold grade in […]
Skanska invests SEK 230 million in housing project in Helsinki
Construction company Skanska is investing EUR 21 million, corresponding to approximately SEK 230 million, in a housing project with 50 apartments in Helsinki, Finland. The project will achieve the highest energy rating and aims for the YL environmental classification. Parts of the roof will be designed as a green roof. Construction is scheduled to start […]
Cantargia selects IL-17 as target for CAN14
The biotechnology company Cantargia has selected IL-17 as the second biological target for the bispecific antibody CAN14. The drug candidate, which is in preclinical development, is designed to simultaneously inhibit IL1RAP and IL-17 signaling. The aim is to improve the treatment of chronic inflammatory diseases by targeting multiple inflammatory signaling pathways at the same time. […]
BNP Paribas upgrades Sanofi to outperform from neutral, price target EUR 102 (79) – BN
BNP Paribas upgrades Sanofi to outperform from neutral, price target EUR 102 (79) – BN
Nordea raises the price target for Schouw & Co. to 950 Danish kroner (895), reiterates Buy
Nordea raises the price target for Schouw & Co. to 950 Danish kroner (895), reiterates Buy
Nordea initiates coverage of Biogaia with Buy rating – price target of SEK 140
Nordea initiates coverage of probiotic company Biogaia with a Buy rating and a price target of SEK 140, corresponding to a P/E ratio of 29 for 2027. The bank sees support for continued double-digit growth through increased pricing and new premium products. Nordea expects annual revenue growth of 13 percent during 2025–2030, clearly above consensus, […]
Double Bond decides on SEK 10.2 million rights issue
The pharmaceutical company Double Bond Pharma has decided on a rights issue of approximately SEK 10.2 million before issue costs. The issue is covered to approximately 45.1 percent by subscription undertakings from, among others, two major shareholders. The subscription price is SEK 0.11 per share, and twelve existing shares entitle the holder to subscribe for […]
Nordea maintains Hold on Auroora ahead of results report – considers discount justified
Nordea maintains its Hold rating on Finnish industrial acquirer Auroora with a price target of EUR 9.60 ahead of the report on November 19. The bank expects revenue growth of 36 percent in the third quarter, of which approximately 15 percent is organic, and adjusted EBITA of EUR 7.5 million. The stock is valued at […]